Factive and Tagamet
Determining the interaction of Factive and Tagamet and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Coadministration with cimetidine has been shown to slightly increase the plasma concentrations of gemifloxacin. According to the product labeling, cimetidine (400 mg four times a day for 7 days) increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of gemifloxacin (320 mg single dose) by an average of 6% and 10%, respectively. These increases are not considered clinically significant.
- "Product Information. Factive (gemifloxacin)." GeneSoft Inc, San Francisco, CA.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Factive-Tagamet HB
- Factive-Tagraxofusp
- Factive-Tagraxofusp-erzs
- Factive-Tagrisso
- Factive-Take Action
- Factive-Talacen
- Tagamet-Factor IX (Human)
- Tagamet-Factor IX (Human), Factor IX Complex (Human)
- Tagamet-Factor IX (Recombinant [Albumin Fusion Protein])
- Tagamet-Factor IX (Recombinant [Fc Fusion Protein])
- Tagamet-Factor IX (Recombinant [Glycopegylated])
- Tagamet-Factor IX (Recombinant)